Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Surgery. 2012 Oct 25;153(3):333–343. doi: 10.1016/j.surg.2012.09.003

Figure 5.

Figure 5

The responsiveness of SK-Mel 5 and SK-Mel 3 melanoma cells to β-interferon (β-IFN). Cells were incubated with varying concentrations of β-IFN (0 to 40,000 IU/mL/100,000 cells) for 8 h and then challenged with rwt-VSV or M51R-VSV (MOI of 5 pfu/cell). Cell viability was measured by MTS assay 48 h after VSV infection. Data are expressed as the percentage of β-IFN treated, mock-infected cells and presented as the mean ± standard deviation of three independent experiments.